TRADITIONAL PHARMA FACILITIES
Breaking Barriers in bioanalytical automation
Microbiological QC Bottlenecks in Biopharma
Fine-tuning AI Models for Molecular Co-folding
Rethinking Biotech Valuation
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Powder Systems Limited
Tendering Manager Asia-Pacific
Powder Systems Limited PSL has been exporting its technology to the AsiaPacific market since and a growing number of turnkey installations are to be commissioned in this region in the future To support the demand PSL has committed to further investment in AsiaPacific APAC by opening an engineering and sales office in Singapore This addition to PSL APAC will reinforce the fast growing activities c...
Articles
The Role of Genomics in Shaping the Future of Medicine
Sequencing of the Human Genome at the beginning of the st century followed by the technological advances in Next Generation Sequencing NGS bioinformatics analysis tools and computational fire power have helped in making sequencingbased tests affordable and accessible for diagnostics and research purposes This has brought about a revolution in the field of modern medicine impacting greatly the drug...
Research Insights
Evaluation Of Ion Exchange Processes In Drug-eluting Embolization Beads By Use Of An Improved Flow-through Elution Method
Abstract An improved method for evaluating drug release behaviour of drugeluting embolization beads DEBs was developed utilizing an openloop flowthrough system in which the beads were packed into an occlusive mass within the system and extracted with a flowing elution medium over time Glass beads were introduced into the beads mass in order to ensure lam
Case Studies
Pharma Connects On Social: Top 20 Pharmaceutical Companies On Social Media
Abstract Pharmaceutical companies have taken a long time to start using social media in the first place but the industry is still struggling to fully embrace the digital space There are now more than two billion active social media users almost a third of the worlds population Customers are talking about health on the internet and in recent years s
Techno Trends
Sanofi Unveils Ground breaking Dupixent Therapy for Chronic Obstructive Pulmonary Disease
Sanofi has introduced Dupixent a groundbreaking addition to maintenance therapy for adults suffering from uncontrolled chronic obstructive pulmonary disease characterised by elevated blood
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
The New Pharmacovigilance Era
With over 15 years of experience, Aarti brings deep expertise across pharmaceutical contract research services and technology‑enabled drug discovery and development. She leads the Contract Research Services program, covering peripheral and ancillary service segments such as tech vendors, eClinical solution providers, central labs, and related ecosystems. Her strengths span market intelligence, forecasting, competitive benchmarking, and strategic opportunity assessment as well as growth advisory services, that consistently support executive decision‑making for global clients. She is regarded as a trusted growth expert, and is adept in supporting stakeholders navigate industry disruption, accelerate innovation, and seize transformative opportunities across the rapidly evolving Contract Services Landscape.
How Big Data is Transforming Clinical Trials in Asia
I’m Atharva, a content writer currently at Consegic Business Intelligence. With over 3 years of professional experience, I've specialised as a ghostwriter for prominent companies and industry publications, exploring various topics.
Revolutionising Drug Discovery and Development with Artificial Intelligence
13+ years of healthcare and life sciences industry experience in growth consulting and market intelligence. Aarti Chitale has a strong understanding of pharma and biopharma industry especially the Technology enabled Drug Discovery and Development and Contract Pharma services Industry with keen interest in Emerging Business Models and new growth avenues.
Is Convex Dose Dependence A Side Effect That Multiple Drug Treatment Causes?
Y-h. Taguchi obtained Dr. Sci. of Physics from Tokyo Institute of Technology. He has published papers in major journals, including Scientific Reports and PLoS ONE,a monograph from Springer International and is serving as academic editors in journals including PLoS ONE, BMC Medical Genomics and Frontiers in Genetics:RNA.
TurkiTurki received a PhD in computer science from the New Jersey Institute of Technology. He has published papers in journals, including Expert Systems with Applications, Knowledge-Based Systems, and PLoS ONE. Dr. Turki is an editorial board member of Computers in Biology and Medicine and Sustainable Computing: Informatics and Systems.
The Transformative Impact of AI on Regulatory Affairs
Yu Han, DPhil in Engineering Science from the University of Oxford, brings a rich background with experience at manufacturer, global regulatory affairs CRO, and AI sector. Her expertise spans the regulatory landscapes of Asia, the US, and the EU, providing a comprehensive understanding of global pharmaceutical regulations. Passionate about combining AI technology with healthcare, Yu excels in creating innovative engineering tools to advance medical solutions. Her work leverages engineering methodologies to unravel complexities in the medical listing process, streamlining the global product flow.
<p> </p>
Email: yu.han@eng.ox.ac.uk
press releasesRead more...
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
AbbVie and Apogee Therapeutics today announced they have entered into a definitive agreement under which AbbVie will acquire Apogee and its diverse pipeline of multiple clinicalstage candidates in development across inflammatory
ICON Selects Microsoft as a Preferred Technology Partner to Power AI-Enabled Clinical Development
ICON plc NASDAQ ICLR today announced that it has selected Microsoft as a preferred technology partner further advancing ICONs previously announced plan to invest in digital innovation and AI over the next three years
CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors
CARsgen Therapeutics Holdings Limited Stock Code HK a company focused on developing innovative CAR Tcell therapies announced that as informed by the National Medical Products Administration NMPA today
DoH and Sanofi Partner to Advance Vaccine Innovation
The Department of Health Abu Dhabi DoH the regulator of the healthcare sector in Abu Dhabi and Sanofi a worldwide biopharma and vaccines leader have signed an Memorandum of Understanding
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
Informa Markets Korea has officially opened preregistration for CPHI Hi Korea taking place at COEX Seoul from August to Preregistered visitors enjoy complimentary entries
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
The Ministry of Health Labour and Welfare in Japan has granted approval for Sarclisa isatuximab subcutaneous SC formulation in combination with approved standardofcare regimens for the treatment of multiple myeloma
EventsRead more...
23 - 24
Jun 2026Supply Chain USA 2026
Chicago, IL
24 - 25
Jun 20266th Edition Drug Safety Symposium 2026
Courtyard by Marriott, Mumbai,...
25 - 26
Jun 2026Pharmacology and Toxicology 2026
Paris, France
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
LATEST NEWSRead more...
Lonza and InduPro Sign Licensing Agreement to Advance Next-Generation ADC Therapies
Lonza and InduPro have entered into a licensing agreement to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment
Bayer Partners with Iambic to Advance AI-Driven Drug Discovery
Bayer has entered into a drug discovery collaboration with Iambic Therapeutics a clinicalstage biotechnology company that develops medicines using artificial intelligence The partnership will focus on the discovery of smallmolecule therapies
Greenstone Biosciences and Intel Partner to Advance AI-Driven Drug Discovery
Greenstone Biosciences Inc has entered into a strategic collaboration with Intel Corporation to accelerate AIenabled drug discovery by combining Greenstones largescale human induced pluripotent stem cell iPSC biobank with Intels advanced AI and computing infrastructure
SK pharmteco Partners with OTXL to Advance Rare Disease Therapies
SK pharmteco has entered into a strategic collaboration with the Orphan Therapeutics Accelerator OTXL to support the development and manufacturing of treatments for rare diseases
Boltz Collaborates with Takeda to Expand Use of Biomolecular AI Models in Drug Discovery
Boltz PBC has announced a collaboration with Takeda to deploy its advanced biomolecular artificial intelligence models and platform across Takedas research organisation
Insilico Reaches First Clinical Milestone for AI-Developed NLRP3 Inhibitor ISM8969
Insilico Medicine has completed firstinhuman dosing in the Phase I clinical study of ISM marking the first clinical milestone in its codevelopment partnership with Hygtia Therapeutics ISM is an orally administered
